People · Operator
Named in public records as an officer, director or promoter · active 2011–2026 · Investment Vehicle, Other, Medical Devices, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EAG Holdings LP | — | Investment Vehicle | Growth/Late | $2.2B | $19.0B | 2026 |
| S-I IPVF Holdings, LLC | — | Other | Series D+ | $311.3M | $5.4B | 2012 |
| Vistage Holdings, LLC | — | Other | Series D+ | $120.3M | $2.1B | 2012 |
| Regent Surgical Health Topco, L.P. | — | Medical Devices | Series B | $23.7M | $498.4M | 2021 |
| BioMarker Strategies LLC | — | Biotechnology | Seed | $7.9M | $23.3M | 2011 |
Glenn Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glenn Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Bilzin | 2 | 3 |
| Joseph T. Clark | 1 | 63 |
| John Connolly | 1 | 14 |
| Robert Ryan | 1 | 8 |
| Christopher Bishop | 1 | 6 |
| Matthew Lau | 1 | 5 |
| Greg Miller | 1 | 5 |
| Ian Sacks | 1 | 3 |
| Jack Davis | 1 | 3 |
| Jason Rubin | 1 | 3 |
| Peter J. Campbell | 1 | 2 |
| Craig Bouchard | 1 | 2 |
| Joseph Klein | 1 | 2 |
| Hunter Carpenter | 1 | 2 |
| Travis Messina | 1 | 2 |
| Mark Velleca | 1 | 2 |
| Katarzyna Kusmierz | 1 | 2 |
| Douglas Clark | 1 | 2 |
| Leon D. Shapiro | 1 | 2 |
| Joseph Sinicropi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.